Home/Filings/4/0001140361-24-043798
4//SEC Filing

Hagen Heidi 4

Accession 0001140361-24-043798

CIK 0000887359other

Filed

Oct 20, 8:00 PM ET

Accepted

Oct 21, 4:05 PM ET

Size

10.8 KB

Accession

0001140361-24-043798

Insider Transaction Report

Form 4
Period: 2024-10-17
Hagen Heidi
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2024-10-17$3.74/sh+6,000$22,44028,650 total
  • Exercise/Conversion

    Common Stock

    2024-10-17$3.74/sh+4,000$14,96022,650 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-10-17+6,0009,000 total
    Exercise: $3.74Common Stock (6,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-10-17+4,0000 total
    Exercise: $3.74Common Stock (4,000 underlying)
Footnotes (4)
  • [F1]The Reporting Person has elected to exercise and hold these shares at this time.
  • [F2]These options, representing the right to purchase 4,000 shares, became exercisable in three installments, contingent upon continued service to the Company, with the first vesting date on March 20, 2015, which was the date on which the option was granted, and the final vesting date on May 1, 2015.
  • [F3]These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025.
  • [F4]These options, representing the right to purchase 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015, and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017.

Issuer

Vericel Corp

CIK 0000887359

Entity typeother

Related Parties

1
  • filerCIK 0001585084

Filing Metadata

Form type
4
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 4:05 PM ET
Size
10.8 KB